APO C200 (Carbamazepine extended-release 200 mg)
Pill imprint APO C200 has been identified as Carbamazepine extended-release 200 mg.
Carbamazepine is used in the treatment of trigeminal neuralgia; bipolar disorder; epilepsy; schizoaffective disorder; peripheral neuropathy (and more), and belongs to the drug class dibenzazepine anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Carbamazepine 200 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for APO C200 (Carbamazepine extended-release 200 mg)
More about carbamazepine
- Carbamazepine chewable tablets
- Carbamazepine suspension
- Carbamazepine sustained-release capsules
- Carbamazepine sustained-release tablets
- Carbamazepine (Advanced Reading)